| Stage | OSCR | % of rev | PRAA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.9B | 100.00% | $372M | 100.00% | OSCR ×13.11 |
| Gross profit | $1.1B | 22.25% | $302M | 81.09% | PRAA +58.8pp |
| Operating income | $389M | 7.96% | $153M | 41.19% | PRAA +33.2pp |
| Pre-tax income | $383M | 7.85% | $88M | 23.73% | PRAA +15.9pp |
| Net income | $362M | 7.41% | $59M | 15.84% | PRAA +8.4pp |
| Stage | OSCR | PRAA | Gap · A − B |
|---|---|---|---|
| Revenue | $4.9B100.00% | $372M100.00% | OSCR ×13.11 |
| Gross profit | 22.25%$1.1B | 81.09%$302M | PRAA +58.8pp |
| Operating income | 7.96%$389M | 41.19%$153M | PRAA +33.2pp |
| Pre-tax income | 7.85%$383M | 23.73%$88M | PRAA +15.9pp |
| Net income |
| 7.41%$362M |
| 15.84%$59M |
| PRAA +8.4pp |
No disclosed counterparties: PRAA.
None